Plasma triglyceride concentrations were shown to be higher in hypertensive (153±2 mm Hg) male Dahl salt-sensitive rats than in control Sprague-Dawley rats (122 ±2 mm Hg). These differences in triglyceride concentrations were seen when blood was drawn at 9 AM from unfasted animals (229±27 versus 111±8 mg/dL), at 1 PM after a 4-hour fast (186±13 versus 88±4 mg/dL), or at 9 AM after a 13-hour fast (151±6 versus 90±6 mg/dL), all p<0.001. Total triglyceride secretion was also compared in groups of rats by determining the increment in plasma triglyceride concentration for 2 hours after blocking triglyceride removal from plasma by injecting Triton. Studies performed at 1 PM and 9 AM, after the 4-and 13-hour fast, demonstrated that total triglyceride secretion was greater (p<0.05) in Dahl rats only when studied at 1 PM. Direct estimates of hepatic triglyceride secretion at 1 PM also demonstrated a significant (p<0.02) increase in secretion rate by perfused livers from Dahl rats, due in part to their increased liver size. In addition, removal of prelabeled very low density lipoprotein-triglyceride in the intact rat was significantly (p<0.05) decreased in Dahl rats. Lipoprotein lipase activity measured in skeletal muscle, heart, and adipose tissue was also significantly decreased at 9 AM and 1 PM (after 0 and 4 hours of fasting) in tissue from Dahl rats. These data confirm that Dahl rats have higher plasma triglyceride concentrations than Sprague-Dawley rats. Since both total and hepatic triglyceride secretion were somewhat greater in Dahl rats, in association with a decrease in both removal of very low density lipoprotein from plasma and decreased muscle and adipose tissue lipoprotein lipase activity, it seems likely that hypertriglyceridemia in Dahl rats results from a combination of increased triglyceride secretion and decreased triglyceride removal. 1 Since hypertriglyceridemia has also been noted in patients with hypertension, 23 as well as in two other models of rodent hypertension, 45 it seemed possible that an increased understanding of the cause of hypertriglyceridemia in a rodent model of hypertension would provide useful information relevant to the change in lipoprotein metabolism seen in patients with high blood pressure. As a first step in this process, we initiated a series of studies to define the mechanism of hypertriglyceridemia in Dahl S rats. Increased plasma very low density lipoprotein-TG (VLDL-TG) concentration in Dahl S rats may be due to increased hepatic VLDL-TG secretion, decreased VLDL-TG removal, or both, with the latter process dependent on the activity of lipoprotein lipase (LPL). 6 We determined TG secretion in both the intact
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t has recently been demonstrated that plasma triglyceride (TG) concentration is increased in Dahl salt-sensitive (Dahl S) rats. 1 Since hypertriglyceridemia has also been noted in patients with hypertension, 23 as well as in two other models of rodent hypertension, 45 it seemed possible that an increased understanding of the cause of hypertriglyceridemia in a rodent model of hypertension would provide useful information relevant to the change in lipoprotein metabolism seen in patients with high blood pressure. As a first step in this process, we initiated a series of studies to define the mechanism of hypertriglyceridemia in Dahl S rats. Increased plasma very low density lipoprotein-TG (VLDL-TG) concentration in Dahl S rats may be due to increased hepatic VLDL-TG secretion, decreased VLDL-TG removal, or both, with the latter process dependent on the activity of lipoprotein lipase (LPL). 6 We determined TG secretion in both the intact method, without external preheating, was used to measure the systolic blood pressure. Ambient temperature was kept at 30°C. The equipment used included magnetic animal holders connected to a manual scanner (model 65-12, IITC, Woodland Hills, Calif.), a pulse amplifier (model 59, IITC), and a dual-channel recorder (model 1202, Linear Instruments, Reno, Nev.). The systolic blood pressure was measured while the rats were in the conscious state. Each rat was acclimated to the holder and tail cuff by two to three training sessions several days before the definitive measurements. On the day of the test, the mean of five consecutive readings was taken as the measurement of systolic blood pressure for each rat.
Trigfyceride Secretion Rate
Triglyceride secretion rate (TGSR) was determined by measuring the increase in plasma TG concentration after suppression of TG removal from plasma with Triton WR 1339. 8 - 9 These studies were performed under two conditions. In one series of studies, food was removed at 8:30 AM, and Triton was injected between 12:30 and 1:30 PM. In a second series of experiments, food was removed at 9 PM, and Triton was injected between 9 and 10 AM. In both instances, blood samples were obtained before injection of Triton for measurement of TG concentration with Sigma kit No. 339, modified from the enzymatic method of McGowan et al. 10 Rats were wrapped in a terry cloth towel to partially calm them before a 0.5-mL blood sample was obtained from an incision at the tip of the tail. The cut was sealed with laboratory tape, followed by injection of Triton (300 mg/mL) into the tail vein at a dose of 800 mg/kg body wt. Animals were returned to their cages, and subsequent blood samples of 0.2 mL were obtained for TG determination 60 and 120 minutes after injection of Triton.
Hepatic Triglyceride Production
Livers were isolated from S-D and Dahl S rats and perfused by established techniques in our laboratory.
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These animals were fasted at 8:30 AM, and perfusions were started between 12:30 and 1:30 PM. The perfusing medium consisted of 36% red blood cells, suspended in Krebs-Ringer bicarbonate buffer containing 4 g bovine serum albumin (BSA)/100 mL. The red blood cells were human salvage cells obtained from the Stanford University Blood Bank and used within 14 days of collection. On the day of perfusion, red blood cells were washed repetitively (4-5 times) with physiological saline solution containing KC1 at 4.5 meq/L, followed by a final wash with Krebs-Ringer bicarbonate solution. At the start of perfusion, livers were initially flushed with 30 mL perfusing medium containing glucose (8 mM), free fatty acid (0.60 /Aeq/mL), insulin (4 ng/mL), and amino acids at physiological levels, followed by recirculation with a perfusate volume of 58 mL. During the next 120 minutes, all livers received an infusion of oleic acid and insulin to sustain perfusate free fatty acid concentrations at 0.60 /xeq/mL and insulin concentrations of 8 ng/mL, respectively. Hepatic TG secretion was calculated from the change in perfusate TG concentration between 30 and 120 minutes, corrected for sampling losses, and expressed as net milligrams TG produced per hour per gram liver and milligrams TG per hour per gram liver.
Very Low Density Lipoprotein-Triglyceride Removal
VLDL-TG removal rates were determined by measuring the rate of disappearance of prelabeled VLDL-TG from the plasma of intact animals. The labeled VLDL was prepared by injecting 300-400-g donor rats with 400 ^tCi 2-[ 3 H]glycerol via the tail vein. The donor rats were exsanguinated under methoxyflurane anesthesia 40 minutes later. The blood was defibrinated, and the serum was separated by centrifugation. The serum then underwent ultracentrifugation through a 0.9N NaCl solution, pH 7.3, containing 0.01% EDTA. The recovered VLDL was subsequently dialyzed against the same solution for two exchanges of at least 6 hours each, followed by one overnight exchange against 0.9N NaCl solution without EDTA. Aliquots of this purified VLDL were then injected into rats from each experimental group. After administration of the label, 0.4 mL blood was collected into 1.5-mL centrifuge tubes at 3,6,9, and 12 minutes. These collections, timed with a stopwatch, took approximately 30 seconds to collect from the end of the tail, and the time used for the sampling point was calculated from the beginning and ending times of the blood collection. After storage on ice, the serum was separated after 2 minutes of centrifugation in a microcentrifuge, and aliquots were taken for determination of lipid extractable radioactivity and TG concentration. Lipid extraction was performed by the method of Folch et al, 12 and radioactivity was measured by liquid scintillation counting (Beckman LD) using a standard aqueous scintillation mixture. The counts recovered from the lipid extraction procedures were >95% of those in the plasma, indicating that the material injected was present almost entirely in lipid form. The half-time (tl/2) of VLDL-TG removal was determined directly from these measurements by a least-squares linear regression analysis.
Lipoprotein Lipase Activity
Two sets of experiments were performed. In the first study, 21 rats (11 Dahl S and 10 S-D) were anesthetized with sodium thiamylal (68 mg/kg i.p.) between 8:30 and 9:30 AM, whereas in the second experiment, 20 rats (10 Dahl S and 10 S-D) were anesthetized between 12:30 and 1:30 PM. Blood was collected and centrifuged; serum was obtained, aliquoted, and frozen for later analysis of TG concentration. In both instances, rats had free access to food and water until 8:30 AM. The body weights of the 21 Dahl S rats (268 ±1 g) and the 20 S-D rats (267 ±2 g) were similar.
Soleus and vastus intermedius skeletal muscles were removed first, followed by removal of the liver, epididymal fat pad, and heart. All tissues were rapidly frozen between blocks of solid CO 2 , enclosed in plastic bags, and stored at -90°C. Fragments (50-100 mg) of each tissue were homogenized for measurement of total protein content according to Lowry et al.' 3 Fat cell number was quantified on cells isolated with collagenase as previously described, 14 lipid content determined by Dole extraction, 15 and fat cell size (micrograms TG per cell) calculated by dividing the adipose cell number into total depot lipid.
Total LPL activity was measured after detergent extraction, as described by Iverius and Brunzell. 16 Tissue fragments (adipose tissue, 100-150 mg; soleus, 60-100 mg; vastus intermedius, 80-150 mg; and heart, 100-150 mg) were homogenized in a polytron (Brinhaven Instruments) in 1 mL extraction buffer (5% deoxycholate, 0.2 M Tris, 0.25 M sucrose, 1% BSA, 10 units/mL heparin, and 0.02% nonidet P 40; pH 8.3) and centrifuged for 15 minutes at 12,000 rpm. Aliquots of the supernatant for muscles and the infranatant below the fat cake for adipose tissue were then diluted 1:15 with detergent-free extraction buffer. Either 100 or 150 fiL were then mixed with 150 fiL radioactive glycerolstabilized triolein of Nilsson-Ehle and Schotz 17 substrate emulsion containing, as a source of apo CII, fasted human serum. The media was incubated for 1 hour at 37°C in a water bath. Nonspecific LPL activity for each sample was determined by incubating each sample with 150 /xL substrate emulsion that did not contain fasted human serum. Interassay variations and linearity of the assay were controlled by running a standard curve of a pooled rat postheparin plasma (1:20 dilution). One unit of LPL activity is defined as 1 fimol FFA released per hour. 17 Hepatic lipase activity was measured as described by Doolittle et al. 18 A portion of frozen liver (-100 mg) was homogenized in a polytron in 1 mL solubilization buffer (5 mM sodium barbital, 0.15 M NaCl, 10 units/mL heparin; pH 7.4) and centrifuged once at 60,000 rpm for 60 minutes. Aliquots (150 /iL) were then mixed with 150 fiL radioactive glycerol-stabilized triolein of Nilsson-Ehle and Schotz 17 substrate emulsion and incubated without serum for 1 hour at 37°C in a water bath. 18 One unit of hepatic lipase activity is defined as 1 /nmol FFA hydrolyzed per gram per kilogram.
Calculations and Statistical Analysis
The formulas used to determine TGSR and tl/2 with the two experimental methods used were as follows:
where TGSR is expressed in milligrams per 100 grams body weight per hour, TG in milligrams per milliliter, and plasma volume in milliliters per 100 grams body weight. TG concentration was measured as described earlier. Plasma volume was determined with iodine-125-labeled albumin as previously described. 18 The tl/2 of VLDL-TG removal was directly determined by following the disappearance of prelabeled VLDL-TG from plasma. The natural logarithm of the counts per minute of each sample was determined and plotted against time. A best-fit line was determined by a least-squares linear regression analysis, and the slope was determined. The following calculations were then made: slope=FTR (fractional turnover rate); tl/2=ln 2/FTR.
Results are expressed as mean±SEM. Student's t test for unpaired data was used to compare blood pressure, hepatic TG production, and VLDL-TG removal of S-D and Dahl S rats. Plasma TG concentrations, TGSR, hepatic lipase activity, and adipose and muscle LPL activity of S-D and Dahl S rats measured under different fasting conditions were compared by two-way analysis of variance. Student's t test was used to examine specific paired comparisons when significant differences were obtained for the main effects of rat strain and length of fast. Differences were considered statistically significant at p< 0.05.
Results
Blood pressure of Dahl S and S-D rats during ad libitum feeding of normal laboratory chow are shown in Figure 1 . The data indicate that mean systolic blood pressure of Dahl S rats was 25% higher (p<0.001) than in S-D rats.
Plasma TG concentrations were determined on blood samples taken from Dahl S and S-D rats after varying periods of fasting. These results are shown in Figure 2 and indicate that plasma TG values were significantly higher (/?<0.001) in Dahl S rats, irrespective of either time of day or duration of time without food. However, it can also be seen from Figure 2 that the longer the period without food, the lower the TG concentrations in both groups.
Plasma TG concentrations before and after injection of Triton are listed in Table 1 as well as the incremental increase in TG concentration after Triton administration (A 0-120 minutes). These data indicate that TG concentrations were significantly higher in Dahl S rats, both before and after injection of Triton, and this was true irrespective of duration of fast. Although the accumulation of TG in plasma was greater in Dahl S rats when measured under both conditions, the TGSR was significantly increased in Dahl S rats only when measured 4-5 hours after food withdrawal.
Basal plasma TG concentrations were also higher in the Dahl S rats used for liver perfusion (176±16 versus 84±9 mg/dL, /><0.001). Although the body weights of the two groups of rats were similar, the liver of Dahl S rats weighed more ( Table 2) . As a result, the percentage of body weight as liver was greater in Dahl S as compared with S-D rats (4.55±0.10 versus 4.06±0.09%, p<0.01). The data in Table 2 also show that hepatic TG FIGURE 
Bar graph shows mean±SEM basal plasma triglyceride (TG) concentrations of Sprague-Dawley (S-D) and Dahl salt-sensitive (Dahl S) rats determined at 9 AM (0900) in nonfasted animals, at 1 PM (1300) after a 4-hour fast, and at 9 AM (0900) after a 13-hour fast. Values represent 10 S-D and 11 Dahl S rats studied without fasting, 25 S-D and 24 Dahl S rats studied after a 4-hour fast, and nine S-D and eight Dahl S rats studied after a 13-hour fast. **p<0.001 as assessed by Student's t test. Two-way analysis of variance indicated a significant difference for type of rat (p<0.001) and length of fast (p<0.01); no significant interaction between the two was noted.
production was significantly greater in Dahl S rats (p<0.02) when expressed as milligrams per hour per liver. On the other hand, when the difference in liver size was taken into account, the increase in hepatic TG production per gram liver in Dahl S rats did not reach statistical significance.
The rate of TG removal from the plasma of S-D and Dahl S rats was quantitated by measuring the half-time of disappearance (tl/2) of endogenously prelabeled VLDL-TG. The upper portion of Figure 3 shows the relative disappearance of radioactive VLDL from animals injected after a 4-6-hour fast. The tl/2 values calculated from these disappearance curves are illustrated in the lower portion of Figure 3 and show a prolongation of (p<0.04) disappearance time of VLDL-TG in Dahl S rats.
Plasma TG concentrations were higher in Dahl S rats when blood was removed at 9 AM without fasting (229±27 versus 111±8 mg/dL,/?<0.001), as well as at 1 PM after a 4-hour fast (186±13 versus 88±4, p<0.001) immediately before obtaining tissue for measurement of LPL (see Figure 2) . Total adipose tissue LPL activity of the two groups of rats at these same times are seen in Figure 4 . It is apparent that values of total LPL activity of adipose tissue from both groups were higher at 9 AM in nonfasted animals than at 1 PM after a 4-5-hour fast (p<0.05). In addition, these results demonstrate that total LPL activity was significantly lower (/?<0.01) in Dahl S rats compared with S-D rats at both times measured. It should be noted that the decrease in LPL activity in Dahl S rats was not due to differences in adipose tissue mass. Specifically, fat cell number (cells per gramxlO 5 Measurements of muscle LPL activity are shown in Figure 5 . It can be seen that the values in all three muscles changed much less as a function of time of day measured, duration of fast, or both than did adipose tissue. The results in the left panel indicate that LPL activity of heart muscle was significantly lower in Dahl S rats when measured at either 9 AM (in the absence of food withdrawal) or 1 PM (after a 4-5-hour period of food withdrawal). The results with the soleus muscle are seen in the middle panel, and as with heart muscle, LPL activity was lower in Dahl S rats at both times measured. Although LPL activity was also lower in the vastus intermedius of Dahl S rats at both time points, the differences at any given time were not statistically significant. On the other hand, when data from both time points were combined and used to compare the two groups, LPL activity of Dahl S rats was significantly lower (p<0.02).
Measurements of hepatic lipase activity are illustrated in Figure 6 and show comparable levels in both groups of rats when measured under nonfasting conditions (9 AM) and after a 4-5-hour fast (1 PM). The duration of the fast did not affect hepatic lipase activity, and the interaction effect was not significant.
Discussion
The results presented provide additional support for the earlier observation that Dahl S rats have higher blood pressure as well as higher plasma TG concentrations than do control S-D rats. 1 This was true when plasma TG concentrations were measured in the morning in nonfasted animals after an overnight fast of 13-15 hours or in the early afternoon after a 4-6-hour period of food withdrawal. In addition, experiments were performed that have yielded useful information as to the cause of the increase in plasma TG concentrations seen in Dahl S rats. In the most general terms, evidence was presented supporting the view that hepatic TG secretion was increased and TG removal from plasma decreased in Dahl S as compared with S-D rats. TG secretion was determined by two techniques: indirectly by determining the increment in plasma TG secretion after the injection of Triton and directly by in situ hepatic perfusion. In both cases it was possible to demonstrate that TG secretion was greater in Dahl S than in S-D rats. TG removal from plasma was also measured directly by following the disappearance of injected radiolabeled VLDL-TG, and the results of these experiments indicated that the tl/2 of removal was significantly greater in Dahl S rats. In support of the evidence that VLDL-TG removal is delayed in Dahl S rats was the demonstration that both adipose tissue and muscle LPL activity were decreased in Dahl S rats.
Although it seems reasonable to conclude that both increased secretion and decreased clearance contribute to hypertriglyceridemia in Dahl S rats, we believe that the defect in VLDL-TG removal from plasma is the more fundamental one. This conclusion is based on the following considerations. Dahl S rats had higher plasma TG concentrations than S-D rats when measured in either unfasted animals or after a 4-or 13-hour fast. However, TG secretion in the intact animal was significantly increased in Dahl S rats only in studies per- formed after a 4-hour but not after a 13-hour fast. Second, when measured at the same time (after a 4-hour fast) TG secretion was only approximately 16% higher, whereas TG removal was approximately 33% lower in Dahl S rats. Third, the decreases in adipose tissue and muscle LPL activity were observed in Dahl S rats, irrespective of the duration of fast, and significant differences were seen at a time when TG secretion rates were similar in Dahl S and S-D rats. In contrast, hepatic lipase activity was not decreased in Dahl S rats in the fed state or after a 4-hour fast. In light of these comparisons, it seems to us that a peripheral TG removal defect played the most central role in the hypertriglyceridemia seen in Dahl S rats. On the other hand, this formulation is not meant to deny that TG secretion was also increased in Dahl S rats, and this change undoubtedly contributed to the increase in plasma TG concentration.
Although the data presented provide a reasonable explanation for the development of hypertriglyceri- demia in Dahl S rats, two fundamental questions remain to be addressed. Elevated plasma TG concentrations are also commonly seen in patients with hypertension, 23 as well as in rats with either spontaneous 5 or fructoseinduced 4 hypertension. It is certainly possible that similar changes in LPL activity also account for the hypertriglyceridemia in these other situations, but this need not be the case, and experiments to test this hypothesis need to be performed. Of greater importance is the need to understand why hypertension and hypertriglyceridemia are associated. We have previously suggested that both abnormalities are related to insulin resistance and compensatory hyperinsulinemia.
3 " 5 ' 19 ' 20 In this context, it should be noted that Dahl S rats also appear to be hyperinsulinemic, and resistance to insulin-stimulated glucose uptake by their isolated adipocytes has also been demonstrated. 21 Furthermore, Milan hypertensive rats have also been shown to be hyperinsulinemic and hypertriglyceridemic. 22 Thus, the combination of insulin resistance, hyperinsulinemia, hypertriglyceridemia, and high blood pressure appears to occur quite commonly. Consequently, it is likely that information gained from the study of hypertriglyceridemic rodents with hypertension will provide mechanistic hypotheses that can be evaluated in patients with both hypertension and hypertriglyceridemia.
